Article Search

Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial

January 1, 2022

Many of us have used platinum/paclitaxel in this setting but this study helps to corroborate the clinical practice.

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

January 1, 2022

Another win for combined target-IO Rx with meaningful OS difference and reasonable/expected tolerability.

Keyword Search

Article Archive (2021)

About This Site

FCS Hematology Oncology Review creates a platform for our physician network to observe the most recent articles and studies available in the oncology and hematology world. By sharing these articles we are building our wealth of knowledge of new observations and treatments as they come available.

Article Search

Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

Keyword Search

Article Search

Cancer Types

Month Contributed

Show FCS Articles Only

Sort Order

Number of Posts

Menu

About This Site